Your browser doesn't support javascript.
loading
Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter-Defibrillator Therapies.
Schupp, Tobias; Behnes, Michael; Weiß, Christel; Nienaber, Christoph; Lang, Siegfried; Reiser, Linda; Bollow, Armin; Taton, Gabriel; Reichelt, Thomas; Ellguth, Dominik; Engelke, Niko; Bertsch, Thomas; Akin, Muharrem; Mashayekhi, Kambis; Borggrefe, Martin; Akin, Ibrahim.
Afiliação
  • Schupp T; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Behnes M; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Weiß C; Institute of Biomathematics and Medical Statistics, University Medical Center Mannheim (UMM), Faculty of Medicine Mannheim, Heidelberg University, Mannheim, Germany.
  • Nienaber C; Royal Brompton and Harefield Hospitals, NHS, London, United Kingdom.
  • Lang S; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Reiser L; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Bollow A; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Taton G; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Reichelt T; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Ellguth D; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Engelke N; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Bertsch T; Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, General Hospital Nuremberg, Paracelsus Medical University, Nuremberg, Germany.
  • Akin M; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Mashayekhi K; Department of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Germany.
  • Borggrefe M; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Akin I; First Department of Medicine, University Medical Centre Mannheim (UMM), European Center for AngioScience (ECAS), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
J Cardiovasc Pharmacol ; 73(5): 272-281, 2019 05.
Article em En | MEDLINE | ID: mdl-30747784
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular / Cardioversão Elétrica / Inibidores da Enzima Conversora de Angiotensina / Taquicardia Ventricular / Desfibriladores Implantáveis / Antagonistas de Receptores de Angiotensina Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Ventricular / Cardioversão Elétrica / Inibidores da Enzima Conversora de Angiotensina / Taquicardia Ventricular / Desfibriladores Implantáveis / Antagonistas de Receptores de Angiotensina Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha